Journal
EXPERIMENTAL LUNG RESEARCH
Volume 31, Issue 6, Pages 563-579Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/019021490951531
Keywords
captive bubble surfactometry; dimeric SP-B1-25 peptide; Fourier transform infrared spectroscopy; lung function; rats
Categories
Funding
- NHLBI NIH HHS [R01 HL055534, HL55534] Funding Source: Medline
Ask authors/readers for more resources
Surfactant protein B (SP-B) is an essential component of pulmonary surfactant. Synthetic dimeric SP-B1-25 (SP-B1-25), a peptide based on the N-terminal domain of human SP-B, efficiently mimics the functional properties of SP-B. The authors investigated the optimum lipid composition for SP-B1-25 by comparing the effects of natural lung lavage lipids (NLL), a synthetic equivalent of NLL ( synthetic lavage lipids SLL), and a standard lipid mixture (TL) on the activities of SP-B1-25. Surfactant preparations were formulated by mixing 2 mol% SP-B1-25 in NNL, SLL, and TL. Calfactant, a calf lung lavage extract with SP-B and SP-C, was a positive control and lipids without peptide were negative controls. Minimum surface tension measured on a captive bubble surfactometer was similar for the three SP-B1-25 surfactant preparations and calfactant. The effects on lung function were compared in ventilated, lavaged, surfactant-deficient rats. Oxygenation and lung volumes were consistently higher in rats treated with calfactant and SP-B1-25 in NLL or SLL than in rats treated with SP-B1-25 in TL. Fourier transform infrared spectra observed abnormal secondary conformations for SP-B1-25 in TL as a possible cause for the reduced lung function. Lipid composition plays a crucial role in the in vitro and in vivo functions of SP-B1-25 in surfactant preparations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available